Heart rhythm disorders, also called arrhythmias, affect millions of people around the world. These conditions happen when the electrical signals that tell the heart when to beat become disturbed.
Instead of beating in a steady pattern, the heart may beat too fast, too slowly, or in an uneven rhythm. Some arrhythmias cause only mild symptoms, while others can lead to fainting, stroke, heart failure, or even sudden cardiac death.
Although doctors have medicines and medical procedures to treat many rhythm problems, some rare forms remain very difficult to control.
A new study from The Ohio State University has uncovered an important clue about how certain dangerous arrhythmias develop. The discovery gives scientists a better understanding of the heart’s electrical system and may eventually lead to safer and more targeted treatments for people with life-threatening rhythm disorders.
The research was led by assistant professor Przemysław Radwanski and focused on a tiny protein called calmodulin. Although calmodulin is very small, it is found in almost every cell in the body and plays an important role in many normal body functions.
In the heart, calmodulin helps control the movement of calcium and sodium, two charged particles that are essential for every heartbeat.
Every heartbeat depends on carefully controlled electrical signals. Sodium helps start the electrical signal that travels through the heart, while calcium helps heart muscle cells contract and pump blood to the rest of the body.
These two minerals must move into and out of heart cells in the correct amounts and at the right time. If this balance is disturbed, the heartbeat can become abnormal.
Doctors can observe the heart’s electrical activity using an electrocardiogram, often called an ECG or EKG. This simple test records the heart’s electrical signals and helps doctors detect many rhythm problems. However, in some people, especially children and young adults, inherited genetic changes make these rhythm disorders much more serious.
Some people are born with rare changes, known as mutations, in the gene that produces calmodulin. These inherited conditions are called calmodulinopathies. Even though they are uncommon, they can cause severe arrhythmias that are difficult to treat and may increase the risk of sudden cardiac death at a young age.
In the new study, the researchers investigated one particular mutation known as D96V-CaM. They discovered that this mutation allows too much sodium to enter heart cells. The extra sodium then interferes with the normal release of calcium inside the cells.
Because calcium is responsible for triggering each heartbeat, this disruption can cause dangerous changes in the heart’s rhythm.
The scientists made another surprising discovery. For many years, researchers believed that the main sodium channel involved in these rhythm disorders was a channel called NaV1.5, which is the most common sodium channel in heart muscle.
Instead, the team found that the D96V-CaM mutation strongly affects a different sodium channel called NaV1.6. Although NaV1.6 is less common in heart tissue, the study suggests it may play a much larger role in dangerous arrhythmias than scientists previously realized.
This finding could have important medical benefits. If researchers can develop medicines that specifically reduce the activity of the NaV1.6 channel, they may be able to prevent dangerous heart rhythms caused by calmodulin mutations.
Such medicines could be more precise than current treatments because they would target the underlying cause instead of only controlling symptoms. Scientists also believe this approach might help some patients with other rhythm disorders involving abnormal sodium channels.
Professor Radwanski explained that the long-term goal is to develop better treatments not only for rare inherited arrhythmias but also for other heart rhythm disorders that share similar biological pathways. The discovery gives researchers a new target for future drug development and opens an exciting area for further investigation.
Although more studies are needed before new medicines become available, the findings represent an important step toward understanding how the heart’s electrical system works at the smallest level. Every new discovery helps researchers move closer to treatments that are more effective and have fewer side effects.
The full study was published in the Journal of Clinical Investigation. As scientists continue to learn more about the proteins and channels that control the heartbeat, future patients with serious arrhythmias may benefit from more personalized treatments that better protect the heart and reduce the risk of sudden cardiac events.
If you care about heart health, please read studies about how eating eggs can help reduce heart disease risk, and Vitamin K2 could help reduce heart disease risk.
For more information about heart health, please see recent studies about how to remove plaques that cause heart attacks, and results showing a new way to prevent heart attacks, strokes.
Copyright © 2026 Knowridge Science Report. All rights reserved.
